Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

PHR

Phreesia (PHR)

Phreesia Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:PHR
FechaHoraFuenteTítuloSímboloCompañía
19/12/202417:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PHRPhreesia Inc
18/12/202414:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:PHRPhreesia Inc
09/12/202416:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PHRPhreesia Inc
09/12/202415:05Business WirePhreesia Announces Third Quarter Fiscal 2025 ResultsNYSE:PHRPhreesia Inc
09/12/202415:01Edgar (US Regulatory)Form 8-K - Current reportNYSE:PHRPhreesia Inc
22/11/202405:48Business WirePhreesia Named to The Software Report’s “Top 100 Software Companies” for the Third Consecutive YearNYSE:PHRPhreesia Inc
01/11/202405:48Business WirePhreesia Sets Release Date for Fiscal Third Quarter 2025 ResultsNYSE:PHRPhreesia Inc
28/10/202405:48Business WirePhreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable IntegrationNYSE:PHRPhreesia Inc
08/10/202405:48Business WirePhreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy PracticesNYSE:PHRPhreesia Inc
03/10/202405:48Business WirePhreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness CampaignsNYSE:PHRPhreesia Inc
01/10/202405:48Business WirePhreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) ModelNYSE:PHRPhreesia Inc
19/09/202405:48Business WireNew Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and AdoptionNYSE:PHRPhreesia Inc
18/09/202417:11Business WireCDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary IncontinenceNYSE:PHRPhreesia Inc
04/09/202415:03Business WirePhreesia Announces Second Quarter Fiscal 2025 ResultsNYSE:PHRPhreesia Inc
29/08/202405:48Business WirePhreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR VaccinationNYSE:PHRPhreesia Inc
08/08/202405:48Business WireBob Glazer Joins Phreesia as Strategic AdvisorNYSE:PHRPhreesia Inc
01/08/202405:48Business WirePhreesia Sets Release Date for Fiscal Second Quarter 2025 ResultsNYSE:PHRPhreesia Inc
30/07/202405:48Business WirePhreesia Now Available on Oracle Healthcare MarketplaceNYSE:PHRPhreesia Inc
10/06/202409:26Business WireNew Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney DiseaseNYSE:PHRPhreesia Inc
30/05/202415:03Business WirePhreesia Announces First Quarter Fiscal 2025 ResultsNYSE:PHRPhreesia Inc
28/05/202405:48Business WirePhreesia Joins the MEDITECH Alliance Program as an Innovator PartnerNYSE:PHRPhreesia Inc
23/05/202415:30Business WirePhreesia’s Amy Patel Named One of PM360’s 2024 ELITE 100NYSE:PHRPhreesia Inc
21/05/202415:30Business WirePhreesia Named as One of Modern Healthcare’s “Best Places to Work in Healthcare” for the Eighth TimeNYSE:PHRPhreesia Inc
14/05/202415:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:PHRPhreesia Inc
14/05/202415:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:PHRPhreesia Inc
14/05/202415:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNYSE:PHRPhreesia Inc
01/05/202405:46Business WirePhreesia’s Alicia Cowley and Natasha Vega Named to MM+M’s ‘Women to Watch’ for 2024NYSE:PHRPhreesia Inc
29/04/202405:48Business WirePhreesia Sets Release Date for Fiscal First Quarter 2025 ResultsNYSE:PHRPhreesia Inc
19/03/202405:48Business WirePhreesia Announces Jack Callahan as New Chief Technology OfficerNYSE:PHRPhreesia Inc
14/03/202415:03Business WirePhreesia Announces Fourth Quarter Fiscal 2024 ResultsNYSE:PHRPhreesia Inc
 Showing the most relevant articles for your search:NYSE:PHR